Durham, North Carolina 27710

  • Depression


This study will examine the effect of antidepressant medication on rates of death and disease in depressed people with chronic heart failure.

Study summary:

Comorbid depression in people with chronic medical illness is a serious public health concern. Depressive disorders lead to increased morbidity, mortality, and poorer outcomes in ischemic heart disease, a leading cause of chronic heart failure (CHF). Evidence suggests that a relationship exists between depression and CHF; studies that examine the way CHF is affected by depression treatments are needed. Participants in this study will be randomly assigned to receive either sertraline or placebo for 12 weeks. Assessments will be made at Weeks 2, 4, 6, 8, 10, and 12. Participants who do not respond to their treatment will have their medication dose adjusted following assessment. Interviews and rating scales will be used to assess depressive symptoms, cognitive status, psychiatric comorbidity, daily and chronic stress, and social support. A follow-up visit will take place 6 months, 1 year, 2 years, and 3 years after study completion.


Inclusion Criteria: - Chronic heart failure - DSM-IV criteria for major depression - Current use of any antipsychotic medication at study entry Exclusion Criteria: - Life-threatening comorbidity with a 50% or higher likelihood of death within 1 year - History of psychoses, bipolar disorder, or severe personality disorder - History of alcohol or drug dependence in the last year - Severe physical disability that may interfere with the study - Neurological impairment - Active suicidal ideations - Current use of antidepressant medication(s) at the start of study medication



Primary Contact:

Principal Investigator
Ranga Krishnan, PhD
Duke University

Backup Contact:


Location Contact:

Durham, North Carolina 27710
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 30, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.